Patent assignee · US · COMPANY

SILVERGATE PHARMACEUTICALS, INC.

27Patents

27Active

27Granted

50Portfolio score

Filing activity: Nov 6, 2012 → Oct 21, 2021

Most-cited patents

Patent	Title	Area	Cited by	Status
US9463183B1	Lisinopril formulations	Human Necessities	27	Active
US8778366B2	Enalapril compositions	Human Necessities	26	Active
US8568747B1	Enalapril compositions	Human Necessities	25	Active
US9616096B1	Lisinopril formulations	Human Necessities	18	Active
US10695329B2	Amlodipine formulations	Human Necessities	13	Active
US9669008B1	Enalapril formulations	Human Necessities	12	Active
US9855214B2	Enalapril compositions	Human Necessities	9	Active
US10894039B2	Amlodipine formulations	Human Necessities	8	Active
US9808442B2	Enalapril formulations	Human Necessities	8	Active
US9814751B2	Lisinopril formulations	Human Necessities	8	Active
US9968553B1	Enalapril compositions	Human Necessities	8	Active
US10799453B2	Amlodipine formulations	Human Necessities	7	Active
US10039800B2	Lisinopril formulations	Human Necessities	7	Active
US10952998B2	Amlodipine formulations	Human Necessities	6	Active
US10265370B2	Lisinopril formulations	Human Necessities	5	Active
US10940177B2	Lisinopril formulations	Human Necessities	4	Active
US10959991B2	Amlodipine formulations	Human Necessities	4	Active
US10039745B2	Enalapril formulations	Human Necessities	4	Active
US10406199B2	Lisinopril formulations	Human Necessities	4	Active
US10772868B2	Enalapril formulations	Human Necessities	3	Active
US11179434B2	Lisinopril formulations	Human Necessities	3	Active
US10154987B2	Enalapril formulations	Human Necessities	3	Active
US10799476B2	Enalapril formulations	Human Necessities	3	Active
US10918621B2	Enalapril formulations	Human Necessities	3	Active
US11040023B2	Enalapril formulations	Human Necessities	2	Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.